glp 1 tirzepatide mounjaro GLP-1 Weight Loss Treatments: Ozempic, Mounjaro, and Other Options| PMN π Tirzepatide (Mounjaro) β hype
Description
semaglutide Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist
Common side effects include mild gastrointestinal symptoms like nausea, which typically subside over time
A note on whole body wellness
According to the SURMOUNT-1 clinical trial, patients using tirzepatide at the highest dose (15 mg weekly) experienced up to 22.5% total body weight loss over 72 weeksgreater than what is typically seen with semaglutide GLP-1
The dose is the same
Simply input the required values, and youll receive precise dosing calculations
